Central Tolerance Development
Central Tolerance Development is a biological process within immune system ontogeny that establishes self-tolerance by eliminating or inactivating self-reactive lymphocyte precursors during their maturation in primary lymphoid organs.
77
Publications
4.1K
Citations
330
Authors
129
Institutions
Publications per year
2017–2026
3
Parents
77
Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects
Rainer Rupprecht, Gerhard Rammes, Daniela Eser et al. · Science · 2009 · 321 citations
Medicine, Neuroscience, Pharmacology +14
Defective Central Tolerance Induction in NOD Mice: Genomics and Genetics
S. Zucchelli, Phil Holler, Tetsuya Yamagata et al. · Immunity · 2005 · 173 citations · Full text
Life Sciences, Genetics, Immunology +14
Kazuhiro Takahashi, Yuko Kozono, Thomas J. Waldschmidt et al. · The Journal of Immunology · 1997 · 159 citations
Life Sciences, Immunology, Pathology +17
1–5 of 77
330
4
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 330
129
Harvard University
Cambridge, United States
5 h-index
15 publications
1.4K citations
University of Iowa
Iowa City, United States
5 h-index
19 publications
1.7K citations

Brigham and Women's Hospital
Boston, United States
3 h-index
10 publications
1.3K citations

University of Alabama at Birmingham
Birmingham, United States
2 h-index
2 publications
137 citations
Duke University Hospital
Durham, United States
2 h-index
9 publications
138 citations
University of Colorado Boulder
Boulder, United States
2 h-index
6 publications
84 citations

The University of Queensland
Brisbane, Australia
2 h-index
3 publications
289 citations
University of California, San Francisco
San Francisco, United States
2 h-index
5 publications
321 citations
1–8 of 129
10 publications · 960 citations
10
h-index
Repository · 9 publications · 200 citations
9
h-index
6 publications · 142 citations
6
h-index
EJP · 5 publications · 138 citations
5
h-index
4 publications · 122 citations
4
h-index
1–5